Anti-CYP2A13 antibodies are used in the immunodetection of the protein cytochrome P450 family 2 subfamily A member 13. In humans, the canonical protein has a reported length of 494 amino acid residues and a mass of 56.7 kDa. Its subcellular localization is in the ER. It is notably expressed in the liver and testis. A member of the Cytochrome P450 protein family, CYP2A13 is known to be involved with metabolic processes. Synonyms for this target antigen include CYP2A, CYPIIA13, cytochrome P450 2A13, cytochrome P450, family 2, subfamily A, polypeptide 13, cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 13, and CPAD. CYP2A13 gene orthologs have been reported in the mouse and rat species. Some CYP2A13 antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. ELISA, Immunocytochemistry, Immunofluorescence, and Immunohistochemistry are also common applications.